Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
Karcinóm pľúc na ASCO 2018
23 septembra, 2020 4:52 pmÚvod Konferencia ASCO 2018 (ďalej iba ASCO 2018) sa niesla v znamení imunoterapie celým spektrom nádorových ochorení, zvlášť to však platilo...
First-line FOLFOX plus panitumumab (Pan) followed by 5FU/LV plus Pan or single-agent Pan as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): The VALENTINO study
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Colorectal) Cancer Abstract number: 3505 Authors: Filippo Pietrantonio, Federica Morano,...
Long-term results of the ADORE trial: Adjuvant oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX) versus 5-fluorouracil and leucovorin (FL) after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Colorectal) Cancer Abstract number: 3501 Authors: Yong Sang Hong, Sun...
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase 3 CELESTIAL trial
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: 4019 Authors: Ghassan K. Abou-Alfa, Tim...
Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: LBA4001 Authors: Thierry Conroy, Pascal Hammel,...
KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Colorectal) Cancer Abstract number: 3514 Authors: Dung T. Le, Petr...
High-Dose Acid Suppression for Preventing Esophageal Adenocarcinoma in Patients With Metaplasia
23 septembra, 2020 4:52 pmJune 4, 2018 Adjuvant chemotherapy with a modified FOLFIRINOX (mFOLFIRINOX) regimen was superior to gemcitabine with regard to disease-free,...
Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: LBA4008 Authors: Janusz Jankowski, John de...
High-Dose Acid Suppression for Preventing Esophageal Adenocarcinoma in Patients With Metaplasia
23 septembra, 2020 4:52 pmJune 4, 2018 A high dose of a proton-pump inhibitor (PPI) combined with low-dose aspirin reduced the risk of...
Najvýznamnejšie klinické správy z konferencie ASCO 2018 v problematike nádorov gastrointestinálneho traktu
23 septembra, 2020 4:52 pmPočas prvého júnového týždňa tohto roka sa konal v Chicagu tradičný výročný kongres Americkej onkologickej spoločnosti (ASCO). Ako obvykle v rámci prednášok...